Atopic dermatitis (AD) is a chronic disease that affects an increasing number of children and adults. The skin is dry and irritated, and the itching can be so severe that it interferes with sleep and ...

Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in ...

Between an unrelenting itch that interrupts sleep and the social challenges of rashes that can appear anywhere on the body without warning, atopic dermatitis has many ways of raising a person’s stress ...

The study1 by Emma Guttman-Yassky and colleagues represents an important and innovative contribution to the evolving treatment landscape of moderate-to-severe atopic dermatitis, particularly by ...

As the 2026 American Academy of Dermatology (AAD) annual meeting continues in Denver, MedPage Today is offering another preview of its upcoming roundtable on new and emerging developments in atopic ...

Amlitelimab is safe and effective, with potentially progressive efficacy over time, for patients with moderate-to-severe atopic dermatitis.

Already FDA-approved for adults and children 12 years or older, researchers explore extending the nemolizumab age range down to 2 years in atopic dermatitis.

If you have atopic dermatitis, a skin condition commonly known as eczema, prescription creams or other topical medicines and moisturizers are usually enough to manage it. However, if your eczema is ...